{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:51Z","timestamp":1787181891115,"version":"build-2736575974"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["416910386 GRK 2573"],"award-info":[{"award-number":["416910386 GRK 2573"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119800","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:54:42Z","timestamp":1785149682000},"page":"119800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism"],"prefix":"10.1016","volume":"202","author":[{"given":"Marie C.","family":"Kersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Stiewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Gremke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Verena","family":"Taudte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119800_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119800_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119800_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: A pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145707","article-title":"Thymidine phosphorylase associates with DNA damage repair to facilitate stemness maintenance, chemoresistance, and immunosuppression in pan-cancer","volume":"319","author":"Liao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2026.119800_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217307","article-title":"Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine\/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase","volume":"606","author":"Malier","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119800_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.trecan.2022.01.018","article-title":"Multifunctional role of thymidine phosphorylase in cancer","volume":"8","author":"Warfield","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib7","first-page":"6298","article-title":"Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors","volume":"60","author":"Brown","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/bjc.2011.74","article-title":"Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors","volume":"104","author":"Bijnsdorp","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119800_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","article-title":"What is cancer metabolism?","volume":"186","author":"Finley","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119800_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: Insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib12","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1242\/jcs.181016","article-title":"Cancer metabolism at a glance","volume":"129","author":"Vazquez","year":"2016","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: A therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119800_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-022-01263-x","article-title":"Targeting nucleotide metabolism: A promising approach to enhance cancer immunotherapy","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.trecan.2023.04.008","article-title":"Emerging roles of nucleotide metabolism in cancer","volume":"9","author":"Shi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib17","article-title":"Roles of nucleotide metabolism in pancreatic cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119800_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.tcb.2023.03.003","article-title":"Regulation of nucleotide metabolism in cancers and immune disorders","volume":"33","author":"Ali","year":"2023","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119800_bib19","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.gendis.2022.04.018","article-title":"De Novo nucleotide biosynthetic pathway and cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Genes. & Dis."},{"key":"10.1016\/j.biopha.2026.119800_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2018.03.019","article-title":"Thymidine phosphorylase in cancer aggressiveness and chemoresistance","volume":"132","author":"Furukawa","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119800_bib21","article-title":"Thymidine phosphorylase in nucleotide metabolism: Physiological functions and its implications in tumorigenesis and anti-cancer therapy","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119800_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/med.20159","article-title":"The dual role of thymidine phosphorylase in cancer development and chemotherapy","volume":"29","author":"Bronckaers","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2026.119800_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1470-2045(05)01766-3","article-title":"Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment","volume":"6","author":"Toi","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1349-7006.2004.tb02193.x","article-title":"The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression","volume":"95","author":"Akiyama","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib25","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bcp.2007.05.008","article-title":"Targeting platelet-derived endothelial cell growth factor\/thymidine phosphorylase for cancer therapy","volume":"74","author":"Liekens","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119800_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12307-015-0173-y","article-title":"Thymidine Phosphorylase in Cancer; Enemy or Friend?","volume":"9","author":"Elamin","year":"2016","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.biopha.2026.119800_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/fon-2017-0627","article-title":"Thymidine Phosphorylase: The Unforeseen Driver in Colorectal Cancer Treatment?","volume":"14","author":"Tampellini","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tcm.2017.10.003","article-title":"Thymidine phosphorylase: A potential new target for treating cardiovascular disease","volume":"28","author":"Li","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"issue":"Pt1","key":"10.1016\/j.biopha.2026.119800_bib29","first-page":"1","article-title":"Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis","volume":"334","author":"Brown","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119800_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118577","article-title":"Unravelling Thymidine phosphorylase: Mechanisms and multifunctional impact on cardiovascular system \u2013 from bench to bedside","volume":"192","author":"Gajecki","year":"2025","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.biopha.2026.119800_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/187152009787313846","article-title":"2-Deoxy-D-Ribose, a Downstream Mediator of Thymidine Phosphorylase, Regulates Tumor Angiogenesis and Progression","volume":"9","author":"Nakajima","year":"2009","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107823","article-title":"TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies","volume":"224","author":"Chakrabarti","year":"2021","journal-title":"Pharmacol. & Ther."},{"key":"10.1016\/j.biopha.2026.119800_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ctrv.2015.06.001","article-title":"TAS-102, a novel antitumor agent: A review of the mechanism of action","volume":"41","author":"Lenz","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2026.119800_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102987","article-title":"TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination","volume":"152","author":"Roviello","year":"2020","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.biopha.2026.119800_bib35","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2217\/fon-2021-0754","article-title":"Trifluridine\/Tipiracil in the Treatment of Gastric Cancer","volume":"18","author":"Fostea","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"TeSlaa","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119800_bib37","doi-asserted-by":"crossref","first-page":"56081","DOI":"10.18632\/oncotarget.9760","article-title":"Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer","volume":"8","author":"Anderson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119800_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119800_bib40","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/j.1742-4658.2006.05214.x","article-title":"Determining and understanding the control of glycolysis in fast-growth tumor cells","volume":"273","author":"Mar\u00edn-Hern\u00e1ndez","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2026.119800_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cellsig.2019.03.011","article-title":"AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-\u03baB, HIF1\u03b1, MMP2, and MMP9 upregulation","volume":"58","author":"Li","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2026.119800_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30613","article-title":"AKT1 Promotes Tumorigenesis and Metastasis by Directly Phosphorylating Hexokinases","volume":"125","author":"Yu","year":"2024","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2026.119800_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119800_bib44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"P53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by P53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2026.119800_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41419-023-06171-7","article-title":"PI3K\/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer","volume":"14","author":"Deng","year":"2023","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.biopha.2026.119800_bib47","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1038\/s41467-024-50157-8","article-title":"Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer","volume":"15","author":"Lan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: Oncogenic MYC in the driver\u2019s seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119800_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.18","article-title":"Regulation of the pentose phosphate pathway by an androgen receptor\u2013mTOR-mediated mechanism and its role in prostate cancer cell growth","volume":"3","author":"Tsouko","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.biopha.2026.119800_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119800_bib51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ncb2172","article-title":"P53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase","volume":"13","author":"Jiang","year":"2011","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119800_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122890","article-title":"HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications","volume":"352","author":"Taneja","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s12935-020-01612-1","article-title":"Protein kinase function of pyruvate kinase M2 and cancer","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.biopha.2026.119800_bib54","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.febslet.2014.04.011","article-title":"Pyruvate kinase M2 and cancer: An updated assessment","volume":"588","author":"Iqbal","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119800_bib55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nm.3840","article-title":"Negative feedback\u2013defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL","volume":"21","author":"Li","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119800_bib56","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2014.03.052","article-title":"Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer","volume":"157","author":"Cunningham","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119800_bib57","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1038\/s41467-025-59119-0","article-title":"PRPS2 enhances RNA m6A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2025.100034","article-title":"Ribonucleotide reductases in cancer: Mechanisms, clinical progress, and prospects","volume":"1","author":"Chen","year":"2025","journal-title":"Cell. Investig."},{"key":"10.1016\/j.biopha.2026.119800_bib59","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: Biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119800_bib60","series-title":"Macromolecular Protein Complexes IV: Structure and Function","first-page":"155","article-title":"Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update","author":"Long","year":"2022"},{"key":"10.1016\/j.biopha.2026.119800_bib61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00109-021-02131-w","article-title":"SAMHD1 in cancer: Curse or cure?","volume":"100","author":"Schott","year":"2022","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119800_bib62","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/eji.201948491","article-title":"Induction of Samhd1 by interferon gamma and lipopolysaccharide in murine macrophages requires IRF1","volume":"50","author":"Valverde-Estrella","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2026.119800_bib63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-018-0050-1","article-title":"SAMHD1 acts at stalled replication forks to prevent interferon induction","volume":"557","author":"Coquel","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119800_bib64","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2013-04-490847","article-title":"SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage","volume":"123","author":"Clifford","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119800_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113066","article-title":"CD39 \u2013 A bright target for cancer immunotherapy","volume":"151","author":"Guo","year":"2022","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.biopha.2026.119800_bib66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib67","first-page":"1","article-title":"Structural analyses reveal two distinct families of nucleoside phosphorylases","volume":"361","author":"Pugmire","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119800_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.str.2003.11.018","article-title":"Crystal Structure of Human Thymidine Phosphorylase in Complex with a Small Molecule Inhibitor","volume":"12","author":"Norman","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.biopha.2026.119800_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0006-291X(03)00294-8","article-title":"Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency","volume":"303","author":"Mart\u0131\u0301","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012741","article-title":"Active Site Conformational Dynamics in Human Uridine Phosphorylase 1","volume":"5","author":"Roosild","year":"2010","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.biopha.2026.119800_bib71","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acs.biochem.5b01347","article-title":"Computer Simulations Reveal Substrate Specificity of Glycosidic Bond Cleavage in Native and Mutant Human Purine Nucleoside Phosphorylase","volume":"55","author":"Isaksen","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119800_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119800_bib73","article-title":"Thymidine phosphorylase in nucleotide metabolism: Physiological functions and its implications in tumorigenesis and anti-cancer therapy","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119800_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145707","article-title":"Thymidine phosphorylase associates with DNA damage repair to facilitate stemness maintenance, chemoresistance, and immunosuppression in pan-cancer","volume":"319","author":"Liao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2026.119800_bib75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00735915","article-title":"Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5?-deoxy-5-fluorouridine","volume":"32","author":"Eda","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119800_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002960100129","article-title":"IL-1\u03b2-induced expression of matrix metalloproteinases and gliostatin\/platelet-derived endothelial cell growth factor (GLS\/PD-ECGF) in a chondrosarcoma cell line (OUMS-27)","volume":"21","author":"Ieda","year":"2001","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2026.119800_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11060-004-3012-4","article-title":"Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells","volume":"72","author":"Yao","year":"2005","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib78","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/brain\/awv077","article-title":"Astrocytic TYMP and VEGFA drive blood\u2013brain barrier opening in inflammatory central nervous system lesions","volume":"138","author":"Chapouly","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119800_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41419-018-1282-6","article-title":"Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.biopha.2026.119800_bib80","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2006.01.142","article-title":"2-Deoxy-d-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of P38 MAPK","volume":"342","author":"Ikeda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib81","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1038\/sj.onc.1206030","article-title":"The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells","volume":"21","author":"Zhu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119800_bib82","first-page":"1326","article-title":"Relation of Hypoxia-inducible Factor-2\u03b1 (HIF-2\u03b1) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer","volume":"62","author":"Leek","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib83","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s42255-023-00774-2","article-title":"Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions","volume":"5","author":"Skinner","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119800_bib84","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s12276-025-01402-7","article-title":"Uridine as a hub in cancer metabolism and RNA biology","volume":"57","author":"Choi","year":"2025","journal-title":"Exp. & Mol. Med."},{"key":"10.1016\/j.biopha.2026.119800_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-023-06073-w","article-title":"Uridine-derived ribose fuels glucose-restricted pancreatic cancer","volume":"618","author":"Nwosu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119800_bib86","doi-asserted-by":"crossref","first-page":"D498","DOI":"10.1093\/nar\/gkaa1025","article-title":"BRENDA, the ELIXIR core data resource in 2021: New developments and updates","volume":"49","author":"Chang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119800_bib87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-291X(03)01062-3","article-title":"Identification of a novel human uridine phosphorylase","volume":"307","author":"Johansson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13874","article-title":"Uridine phosphorylase-1 promotes cell viability and cell-cycle progression in human epidermal keratinocytes via the glycolytic pathway","volume":"51","author":"Xiao","year":"2024","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2026.119800_bib89","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41467-024-45340-w","article-title":"UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib90","first-page":"6899","article-title":"P53-dependent Suppression of Uridine Phosphorylase Gene Expression through Direct Promoter Interaction1","volume":"61","author":"Zhang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-16907-4","article-title":"UPP1 is a dual biomarker of prognosis and immune microenvironment in IDH wild-type glioblastoma","volume":"15","author":"Qian","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119800_bib92","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1038\/s44319-025-00520-7","article-title":"Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes","volume":"26","author":"Whyte","year":"2025","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2026.119800_bib93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0163-7258(00)00097-8","article-title":"Purine nucleoside phosphorylases: Properties, functions, and clinical aspects","volume":"88","author":"Bzowska","year":"2000","journal-title":"Pharmacol. & Ther."},{"key":"10.1016\/j.biopha.2026.119800_bib94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0003-9861(91)90244-D","article-title":"Allosteric regulation of purine nucleoside phosphorylase","volume":"288","author":"Ropp","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2026.119800_bib95","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","article-title":"Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction","volume":"2","author":"Wang","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119800_bib96","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1084\/jem.191.12.2197","article-title":"Mitochondrial Basis for Immune Deficiency: Evidence from Purine Nucleoside Phosphorylase\u2013Deficient Mice","volume":"191","author":"Arpaia","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119800_bib97","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaci.2011.07.039","article-title":"Effects of purine nucleoside phosphorylase deficiency on thymocyte development","volume":"128","author":"Papinazath","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2026.119800_bib98","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/hmg\/ddn401","article-title":"Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice","volume":"18","author":"L\u00f3pez","year":"2009","journal-title":"Human. Mol. Genet."},{"key":"10.1016\/j.biopha.2026.119800_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160852","article-title":"Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity","volume":"132","author":"Abt","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2026.119800_bib100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2018.10.012","article-title":"Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer","volume":"195","author":"Madak","year":"2019","journal-title":"Pharmacol. & Ther."},{"key":"10.1016\/j.biopha.2026.119800_bib101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0045-2068(91)90051-P","article-title":"Overexpression and substrate specificity studies of phosphodeoxyribomutase and thymidine phosphorylase","volume":"19","author":"Barbas","year":"1991","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib102","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20060513","article-title":"Structural basis for non-competitive product inhibition in human thymidine phosphorylase: Implications for drug design","volume":"399","author":"Omari","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119800_bib103","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1039\/C3MB70453J","article-title":"The kinetic mechanism of Human Thymidine Phosphorylase \u2013 a molecular target for cancer drug development","volume":"10","author":"Deves","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.biopha.2026.119800_bib104","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00795-005-0282-7","article-title":"Localization of thymidine phosphorylase in breast cancer tissue","volume":"38","author":"Kobayashi","year":"2005","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.biopha.2026.119800_bib105","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M008512200","article-title":"Uridine Phosphorylase Association with Vimentin","volume":"276","author":"Russell","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib106","doi-asserted-by":"crossref","first-page":"H721","DOI":"10.1152\/ajpheart.1980.239.6.H721","article-title":"Localization of purine and pyrimidine nucleoside phosphorylases in heart, kidney, and liver","volume":"239","author":"Rubio","year":"1980","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2026.119800_bib107","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/338557a0","article-title":"Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor","volume":"338","author":"Ishikawa","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119800_bib108","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0006-291X(05)80025-7","article-title":"Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity","volume":"184","author":"Usuki","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/356668a0","article-title":"Angiogenic factor","volume":"356","author":"Furukawa","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119800_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/368198a0","article-title":"Angiogenic activity of enzymes","volume":"368","author":"Haraguchi","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119800_bib111","first-page":"1687","article-title":"Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor\/thymidine phosphorylase","volume":"55","author":"Miyadera","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib112","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.celrep.2017.04.061","article-title":"Thymidine Catabolism as a Metabolic Strategy for Cancer Survival","volume":"19","author":"Tabata","year":"2017","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119800_bib113","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/s41598-018-25189-y","article-title":"Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cells","volume":"8","author":"Tabata","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119800_bib114","doi-asserted-by":"crossref","first-page":"B105","DOI":"10.1093\/geronj\/45.4.B105","article-title":"Nonenzymatic Glycosylation, the Maillard Reaction and the Aging Process","volume":"45","author":"Monnier","year":"1990","journal-title":"J. Gerontol."},{"key":"10.1016\/j.biopha.2026.119800_bib115","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-013-1090-4","article-title":"Glycation of Glutamate Cysteine Ligase by 2-Deoxy-d-Ribose and its Potential Impact on Chemoresistance in Glioblastoma","volume":"38","author":"Backos","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2026.119800_bib116","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s11064-010-0251-y","article-title":"2-Deoxyribose Deprives Cultured Astrocytes of their Glutathione","volume":"35","author":"Schmidt","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2026.119800_bib117","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2174\/1389203721666200213104446","article-title":"2\u2019-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species","volume":"21","author":"Rafi","year":"2020","journal-title":"Curr. Protein & Pept. Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib118","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.metabol.2009.07.028","article-title":"2-Deoxy-d-ribose induces cellular damage by increasing oxidative stress and protein glycation in a pancreatic \u03b2-cell line","volume":"59","author":"Koh","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2026.119800_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.10119","article-title":"Cellular response to oxidative stress: Signaling for suicide and survival","volume":"192","author":"Martindale","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2026.119800_bib120","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/ijc.22014","article-title":"2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9","volume":"119","author":"Nakajima","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib121","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1006\/bbrc.2002.6432","article-title":"Molecular Basis for the Inhibition of Hypoxia-Induced Apoptosis by 2-Deoxy-d-ribose","volume":"291","author":"Ikeda","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib122","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/ars.2016.6869","article-title":"Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis","volume":"28","author":"Vara","year":"2018","journal-title":"Antioxid. & Redox Signal."},{"key":"10.1016\/j.biopha.2026.119800_bib123","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1021\/acsomega.8b03447","article-title":"Insights into Substrate and Inhibitor Selectivity among Human GLUT Transporters through Comparative Modeling and Molecular Docking","volume":"4","author":"Ferreira","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2026.119800_bib124","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.92.4.998","article-title":"Thymidine phosphorylase is angiogenic and promotes tumor growth","volume":"92","author":"Moghaddam","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib125","first-page":"1911","article-title":"The Effect of a Thymidine Phosphorylase Inhibitor on Angiogenesis and Apoptosis in Tumors1","volume":"59","author":"Matsushita","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104035","article-title":"2-deoxy-d-ribose (2dDR) upregulates vascular endothelial growth factor (VEGF) and stimulates angiogenesis","volume":"131","author":"Dikici","year":"2020","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.biopha.2026.119800_bib127","doi-asserted-by":"crossref","first-page":"19272","DOI":"10.1074\/jbc.M212670200","article-title":"Thymidine Phosphorylase and 2-Deoxyribose Stimulate Human Endothelial Cell Migration by Specific Activation of the Integrins \u03b15\u03b21 and \u03b1V\u03b23*","volume":"278","author":"Hotchkiss","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib128","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1078-0432.CCR-1176-3","article-title":"Blockage of 2-Deoxy-d-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy","volume":"10","author":"Seeliger","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib129","first-page":"1822","article-title":"The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase\/Akt-dependent process","volume":"63","author":"Yu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjp.0705216","article-title":"Thymidine phosphorylase induces angiogenesis in Vivo and in Vitro: An evaluation of possible mechanisms","volume":"139","author":"Sengupta","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119800_bib131","first-page":"2834","article-title":"Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose","volume":"62","author":"Uchimiya","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib132","doi-asserted-by":"crossref","first-page":"432","DOI":"10.21147\/j.issn.1000-9604.2025.03.11","article-title":"Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation","volume":"37","author":"Sun","year":"2025","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101150","article-title":"Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity","volume":"15","author":"Liu","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.biopha.2026.119800_bib134","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119800_bib135","doi-asserted-by":"crossref","first-page":"596","DOI":"10.21147\/j.issn.1000-9604.2024.06.03","article-title":"Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives","volume":"36","author":"Li","year":"2024","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119800_bib136","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119800_bib137","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119800_bib138","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/metabo14060318","article-title":"Stable Isotope Tracing Analysis in Cancer Research: Advancements and Challenges in Identifying Dysregulated Cancer Metabolism and Treatment Strategies","volume":"14","author":"Hilovsky","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2026.119800_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.128921","article-title":"Spatial metabolomics strategy reveals heterogeneity of prostate cancer based on multi-platform imaging and laser microdissection-gas chromatography-tandem mass spectrometry","volume":"298","author":"Pu","year":"2026","journal-title":"Talanta"},{"key":"10.1016\/j.biopha.2026.119800_bib140","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1038\/s41467-023-43917-5","article-title":"Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology","volume":"14","author":"Hu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119800_bib141","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13048-022-01046-5","article-title":"Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism","volume":"15","author":"Bose","year":"2022","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.biopha.2026.119800_bib142","unstructured":"Lonsurf European Medicines Agency (EMA) 2017."},{"key":"10.1016\/j.biopha.2026.119800_bib143","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2217\/fon-2018-0147","article-title":"Trifluridine\/Tipiracil: An Emerging Strategy for the Management of Gastrointestinal Cancers","volume":"14","author":"Peeters","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib144","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41419-025-07541-z","article-title":"Trifluridine\/tipiracil induces ferroptosis by targeting P53 via the P53-SLC7A11 axis in colorectal cancer 3D organoids","volume":"16","author":"Huang","year":"2025","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.biopha.2026.119800_bib145","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/pca.70013","article-title":"Molecular Mechanisms of Ferroptosis Induced by Eleutherococcus senticosus in Glioblastoma","volume":"36","author":"Song","year":"2025","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.biopha.2026.119800_bib146","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0006-2952(01)00783-3","article-title":"Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine Phosphorylase1","volume":"62","author":"Klein","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119800_bib147","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3390\/molecules28083634","article-title":"Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking","volume":"28","author":"Cui","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119800_bib148","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bioorg.2016.07.010","article-title":"In Silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase","volume":"68","author":"Taha","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib149","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/14756366.2021.2001806","article-title":"Polycyclic nitrogen heterocycles as potential thymidine phosphorylase inhibitors: Synthesis, biological evaluation, and molecular docking study","volume":"37","author":"Aknin","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jinorgbio.2011.07.003","article-title":"Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): A combined experimental and theoretical study","volume":"105","author":"Popovi\u0107-Bijeli\u0107","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2026.119800_bib151","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1620220114","article-title":"Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule","volume":"114","author":"Ahmad","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115741","article-title":"Nucleoside-based anticancer drugs: Mechanism of action and drug resistance","volume":"215","author":"Hruba","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119800_bib153","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1073\/pnas.1524212113","article-title":"[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity","volume":"113","author":"Kim","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119800_bib154","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12032-022-01864-z","article-title":"Regulation of thymidylate synthase: An approach to overcome 5-FU resistance in colorectal cancer","volume":"40","author":"Kumar","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2026.119800_bib155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","article-title":"Equilibrative nucleoside transporters\u2014A review","volume":"36","author":"Boswell-Casteel","year":"2017","journal-title":"Nucleosides Nucleotides & Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119800_bib156","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1021\/acs.jmedchem.3c00770","article-title":"NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors","volume":"66","author":"Cipriano","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119800_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2025.1612181","article-title":"Circulating tumor cells: Indicators of cancer progression, plasticity and utility for therapies","volume":"31","author":"Linkner","year":"2025","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biopha.2026.119800_bib158","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf099","article-title":"Biweekly dosing of trifluridine-tipiracil reduces rates of myelosuppression while maintaining efficacy in patients with metastatic colorectal cancer","volume":"30","author":"Cann","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2026.119800_bib159","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J. Clin. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600836X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600836X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:48:29Z","timestamp":1787179709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600836X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":159,"alternative-id":["S075333222600836X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119800","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119800"}}